The purpose of this study is to evaluate the safety and effectiveness of the Vanquish Water Vapor Ablation Device (“Vanquish”) in subjects with Gleason Grade Group 2 (GGG2) localized intermediate-risk prostate cancer
department
Our physicians use state-of-the-art techniques and technologies to surgically treat colon and rectal diseases.